EcoDrugPlus

Ensembl ID : ENSCMIG00000015751
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSCMIG00000001654
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSCMIG00000002023
Gene Symbol: -
Cross references: -
133 Possible Orthologues:

Ensembl ID : ENSCMIG00000002785
Gene Symbol: -
Cross references: -
155 Possible Orthologues:

Ensembl ID : ENSCMIG00000002894
Gene Symbol: -
Cross references: -
267 Possible Orthologues:

Ensembl ID : ENSCMIG00000002947
Gene Symbol: -
Cross references: -
131 Possible Orthologues:

Ensembl ID : ENSCMIG00000004836
Gene Symbol: -
Cross references: -
272 Possible Orthologues:

Ensembl ID : ENSCMIG00000005172
Gene Symbol: -
Cross references: -
162 Possible Orthologues:

Ensembl ID : ENSCMIG00000006028
Gene Symbol: -
Cross references: -
170 Possible Orthologues:

Ensembl ID : ENSCMIG00000001301
Gene Symbol: RPL10
1 Cross references
397 Possible Orthologues:

Ensembl ID : ENSCMIG00000006086
Gene Symbol: -
Cross references: -
123 Possible Orthologues:

Ensembl ID : ENSCMIG00000006547
Gene Symbol: -
Cross references: -
273 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).